Radiofrequency tissue reduction for turbinate hypertrophy (IPG36)
Fast, easy summary view of NICE guidance on 'ear nose and throat conditions'
The Interventional Procedures Advisory Committee (IPAC) has considered this procedure and NICE has issued a consultation document about its safety and efficacy. Consultation has now ended. IPAC will consider the consultation comments and produce a Final Interventional Procedures Document, which will be considered by NICE before guidance is issued to the NHS in England, Wales, Scotland and Northern Ireland.
The consultation period for this procedure closed on the 21st March 2014
If you wish to be alerted to developments regarding this procedure, including the release of the consultation document, please express your interest here.
Inferior turbinates are ridges inside the nose, covered by mucous membrane, which increase the surface area within the nose and help to filter and humidify inspired air. Inflammation of the mucous membrane (rhinitis) can cause inferior turbinates to swell (turbinate hypertrophy). This narrows the nasal passage, and may cause complete nasal obstruction. Symptoms include breathing difficulties, excessive mucous secretion (rhinorrhoea), postnasal drip, facial discomfort/pain and mid-facial headaches.
Treatment options depend on the duration and severity of turbinate hypertrophy. Medical treatments include corticosteroid injections, nasal corticosteroid sprays and decongestants. Surgical treatments include microdebrider-assisted turbinoplasty and laser-assisted turbinoplasty. These procedures are reserved for patients with persistent symptomatic turbinate hypertrophy that has not responded to medical management, or for patients in whom medical management is contraindicated.
E04.2 Excision of turbinate of nose NEC
Includes: Reduction of turbinate of nose NEC
Y11.4 Radiofrequency controlled thermal destruction of organ NOC
The NHS Classifications Service of NHS Connecting for Health is the central definitive source for clinical coding guidance and determines the coding standards associated with the classifications (OPCS-4 and ICD-10) to be used across the NHS. The NHS Classifications Service and NICE work collaboratively to ensure the most appropriate classification codes are provided. www.connectingforhealth.co.uk/clinicalcoding
- IPG036 Radiofrequency volumetric tissue reduction for turbinate hypertrophy: guidance (web format)
- IPG036 Radiofrequency volumetric tissue reduction for turbinate hypertrophy - guidance
- IPG036 Radiofrequency volumetric tissue reduction for turbinate hypertrophy - information for people considering the procedure, and for the public
- IPG036 Radiofrequency volumetric tissue reduction for turbinate hypertrophy, distribution list
- radiofrequency volumetric tissue reduction for turbinate hypertrophy: consultation document
- radiofrequency tissue reduction for turbinate hypertrophy: overview
- Consent - procedures for which the benefits and risks are uncertain
This guidance has been incorporated into the following NICE Pathways, along with other related guidance and products.
Visit the NICE Pathway: ear nose and throat conditions
This page was last updated: 07 April 2014
Information for the public
Implementation tools and resources
- None available
The summary of the key recommendations in the guidance written for patients, carers and those with little medical knowledge and may be used in local patient information leaflets.
Quick Reference Guide
The quick reference guide presents recommendations for health professionals
The published NICE clinical guidance, contains the recommendations for health professionals and NHS bodies.
The published full clinical guidance for specialists with background, evidence, recommendations and methods used.